These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2471288)

  • 1. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application--clinical experience in 152 cardiac surgical patients.
    Dietrich W; Barankay A; Dilthey G; Henze R; Niekau E; Sebening F; Richter JA
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):92-8. PubMed ID: 2471288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results.
    Fraedrich G; Weber C; Bernard C; Hettwer A; Schlosser V
    Thorac Cardiovasc Surg; 1989 Apr; 37(2):89-91. PubMed ID: 2471287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of postoperative blood loss and donor blood use in heart surgery with aprotinin: experience with various dosages].
    Carrel T; Bauer E; Garcia E; von Segesser L; Niederhäuser U; Schönbeck M; Laske A; Turina M
    Helv Chir Acta; 1991 Sep; 58(3):365-78. PubMed ID: 1722785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose aprotinin to reduce blood loss in patients undergoing redo open heart surgery.
    Biagini A; Comite C; Russo V; Salerno ML; Gemignani R; Pardelli S; Baccellini M; Baroni M; Pugliese S; Maffei S
    Acta Anaesthesiol Belg; 1992; 43(3):181-6. PubMed ID: 1280394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
    Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
    Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
    Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
    Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of high doses of aprotinin in cardiac surgery].
    Carrera A; Martínez MV; García-Guiral M; Herrero E; Peral A; Planas A
    Rev Esp Anestesiol Reanim; 1994; 41(1):13-9. PubMed ID: 7517058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations.
    Ciçek S; Demirkiliç U; Kuralay E; Ozal E; Tatar H
    Ann Thorac Surg; 1996 May; 61(5):1372-6. PubMed ID: 8633944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.
    Smith PK; Datta SK; Muhlbaier LH; Samsa G; Nadel A; Lipscomb J
    Ann Thorac Surg; 2004 Feb; 77(2):635-42; discussion 642-3. PubMed ID: 14759451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of high doses of aprotinin on intra- and postoperative blood loss in surgery with artificial circulation].
    Dement'eva II; Charnaia MA; Dzemeshkevich SL; Shabalkin BV; Iavorovskiĭ AG; Piatnitskaia GKh
    Anesteziol Reanimatol; 1995; (2):91-3. PubMed ID: 7544074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of "low dose" aprotinin in open heart surgery and its plasma concentration].
    Nakamura T; Shimamoto M; Yamazaki F; Fujita S; Yoshimura T; Ueno T; Oyanagi H; Shinozaki T
    Nihon Kyobu Geka Gakkai Zasshi; 1994 Feb; 42(2):188-93. PubMed ID: 7511150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
    Parvizi R; Azarfarin R; Hassanzadeh S
    Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open heart operations without transfusion using a multimodality blood conservation strategy in 50 Jehovah's Witness patients: implications for a "bloodless" surgical technique.
    Rosengart TK; Helm RE; DeBois WJ; Garcia N; Krieger KH; Isom OW
    J Am Coll Surg; 1997 Jun; 184(6):618-29. PubMed ID: 9179119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.